159 related articles for article (PubMed ID: 9667598)
1. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.
Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Kimura J; Shimohama S
Ann Neurol; 1998 Jul; 44(1):110-9. PubMed ID: 9667598
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.
Kihara T; Shimohama S; Sawada H; Honda K; Nakamizo T; Kanki R; Yamashita H; Akaike A
J Neurosci Res; 2002 Nov; 70(3):274-82. PubMed ID: 12391586
[TBL] [Abstract][Full Text] [Related]
3. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death.
Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Shimohama S
J Neurosci Res; 1998 Dec; 54(5):707-19. PubMed ID: 9843162
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
5. Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.
Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
Eur J Pharmacol; 2007 Feb; 557(2-3):132-40. PubMed ID: 17161393
[TBL] [Abstract][Full Text] [Related]
6. New insight into the functional role of acetylcholine in developing embryonic rat retinal neurons.
Yasuyoshi H; Kashii S; Kikuchi M; Zhang S; Honda Y; Akaike A
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):446-51. PubMed ID: 11818389
[TBL] [Abstract][Full Text] [Related]
7. [Neuronal cell death in neurodegenerative disorders and oxidative stress].
Shimohama S; Sawada H; Kihara T; Urushitani M
Rinsho Shinkeigaku; 1999 Jan; 39(1):4-6. PubMed ID: 10377784
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation.
Rosin C; Colombo S; Calver AA; Bates TE; Skaper SD
Glia; 2005 Dec; 52(4):336-43. PubMed ID: 16078234
[TBL] [Abstract][Full Text] [Related]
9. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.
Gassen M; Gross A; Youdim MB
Mov Disord; 1998 Mar; 13(2):242-8. PubMed ID: 9539336
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
[TBL] [Abstract][Full Text] [Related]
11. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
12. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro.
Fasano C; Poirier A; DesGroseillers L; Trudeau LE
Eur J Neurosci; 2008 Oct; 28(8):1480-90. PubMed ID: 18973573
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons.
Yasuyoshi H; Kashii S; Zhang S; Nishida A; Yamauchi T; Honda Y; Asano Y; Sato S; Akaike A
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2273-8. PubMed ID: 10892873
[TBL] [Abstract][Full Text] [Related]
14. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation.
Wersinger C; Chen J; Sidhu A
Mol Cell Neurosci; 2004 Jan; 25(1):124-37. PubMed ID: 14962746
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
Xia Y; Xing JZ; Krukoff TL
Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of peroxide formation as a possible substrate for the neuroprotective action of dihydroergocryptine.
Favit A; Sortino MA; Aleppo G; Scapagnini U; Canonico PL
J Neural Transm Suppl; 1995; 45():297-305. PubMed ID: 8748638
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by dopamine agonists.
Lange KW; Rausch WD; Gsell W; Naumann M; Oestreicher E; Riederer P
J Neural Transm Suppl; 1994; 43():183-201. PubMed ID: 7884400
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
Wang C; Buck DC; Yang R; Macey TA; Neve KA
J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
